1.Identification of a novel CRYGC mutation in a pedigree affected with congenital cataracts.
Jing ZHANG ; Donglan SUN ; Yacong WANG ; Weihong MU ; Yuanyuan PENG ; Dongqing MI
Chinese Journal of Medical Genetics 2019;36(7):697-700
OBJECTIVE:
To explore the genetic basis for a Chinese pedigree affected with congenital cataracts.
METHODS:
Clinical data and peripheral blood samples were collected for the pedigree. Following extraction of genomic DNA, whole exome sequencing was carried out to detect genetic variants. Candidate variants were verified by familial co-segregation analysis and Sanger sequencing. Bioinformatics analysis was carried out to predict the function of mutant genes.
RESULTS:
By comparing variants identified among affected and unaffected individuals, a heterozygous variant, c.110 G>C (p.R37P), was identified in exon 2 of the CRYGC gene among all patients, which also matched the criteria for potential disease-causing mutations. The result was confirmed by Sanger sequencing.
CONCLUSION
The c.110G>C variant of the CRYGC gene probably underlay the congenital cataracts in this pedigree.
Asian Continental Ancestry Group
;
Cataract
;
congenital
;
genetics
;
China
;
Heterozygote
;
Humans
;
Mutation
;
Pedigree
;
gamma-Crystallins
;
genetics
2.Clinical research of lumbar and epidural anesthesia on analgesia efficacy in puerperae with prolonged incubation delivery
Yacong WANG ; Shuli LI ; Xiaoming CHEN
Journal of Clinical Medicine in Practice 2017;21(15):92-94
Objective To explore effect of the lumbar and epidural anesthesia for puerperae with prolonged incubation delivery.Methods A total of 100 puerperae with prolonged incubation delivery were selected, the full-term primiparae with analgesia were as observation group, and primiparae without analgesia were as control group.Observation group was given 2 mL anesthetics(ropivacaine for 2 mg and fentanyl for 10 μg) injected in the subarachnoid gap, and PCA pump was connected after 60 min.After the fetus was delivered, the epidural cavity administration was stopped.The control group implemented routine processing.Labor time, delivery methods, use condition of oxytocin, and neonatal Apgar score were observed.Results The observation group had better analgesic efficacy, and longer second stage of labor than the control group(P<0.01).Observation group had shorter first stage of labor and lower cesarean section rate than the control group.There was no significant difference in third stage of labor and neonatal Apgar scores.Conclusion Lumbar and epidural anesthesia with significant efficacy can shorten the first stage of labor, reduce cesarean section rate and adverse reactions of puerperae and newborns.
3.Clinical research of lumbar and epidural anesthesia on analgesia efficacy in puerperae with prolonged incubation delivery
Yacong WANG ; Shuli LI ; Xiaoming CHEN
Journal of Clinical Medicine in Practice 2017;21(15):92-94
Objective To explore effect of the lumbar and epidural anesthesia for puerperae with prolonged incubation delivery.Methods A total of 100 puerperae with prolonged incubation delivery were selected, the full-term primiparae with analgesia were as observation group, and primiparae without analgesia were as control group.Observation group was given 2 mL anesthetics(ropivacaine for 2 mg and fentanyl for 10 μg) injected in the subarachnoid gap, and PCA pump was connected after 60 min.After the fetus was delivered, the epidural cavity administration was stopped.The control group implemented routine processing.Labor time, delivery methods, use condition of oxytocin, and neonatal Apgar score were observed.Results The observation group had better analgesic efficacy, and longer second stage of labor than the control group(P<0.01).Observation group had shorter first stage of labor and lower cesarean section rate than the control group.There was no significant difference in third stage of labor and neonatal Apgar scores.Conclusion Lumbar and epidural anesthesia with significant efficacy can shorten the first stage of labor, reduce cesarean section rate and adverse reactions of puerperae and newborns.
4.Potential pleiotropism of cancer-related single nucleotide polymorphisms among Chinese population
Yu ZHANG ; Zhangyan LYU ; Lei YANG ; Shengfeng WANG ; Liwen ZHANG ; Chao SHENG ; Zhipeng WANG ; Yacong ZHANG ; Huan WANG ; Yubei HUANG ; Kexin CHEN
Chinese Journal of Preventive Medicine 2021;55(10):1203-1208
Objective:To investigate the potential pleiotropism of cancer-related single nucleotide polymorphisms (SNPs) among Chinese population.Methods:Based on the catalogue of GWAS jointly constructed by the National Human Genome Research Institute and the European Institute of Bioinformatics, according to population origin (Chinese population and non-Chinese population) and disease traits (cancer and non-cancer traits). All SNPs found by GWAS before August 2020 were divided into four categories: cancer in Chinese population, non-cancer in Chinese population, cancer in non-Chinese population and non-cancer in non-Chinese population. The number, correlation and linkage of the four categories of SNPs were described.Results:By August 2020, a total of 196 813 SNPs from 4 096 GWAS were included in the GWAS directory. The information that SNPs refer to unknown or were not related to the disease was excluded, and 117 441 independent SNPs were finally included. There were 619 SNPs related to cancer and 9 569 SNPs related to non-cancer disease in Chinese population, respectively. There were 4 624 SNPs related to cancer and 106 448 SNPs related to non-cancer disease (trait) in non-Chinese population, respectively. Three SNPs, rs2736100, rs6983267 and rs401681, were associated with two or more types of cancer in both Chinese and non-Chinese populations. Seven SNPs, rs7705526, rs2736100, rs10993994, rs2735839, rs4430796, rs174537 and rs9271588, were associated with cancer and non-cancer diseases in both Chinese and non-Chinese populations, respectively.Conclusion:There is a potential pleiotropism of cancer-related SNPs in Chinese population.
5.Potential pleiotropism of cancer-related single nucleotide polymorphisms among Chinese population
Yu ZHANG ; Zhangyan LYU ; Lei YANG ; Shengfeng WANG ; Liwen ZHANG ; Chao SHENG ; Zhipeng WANG ; Yacong ZHANG ; Huan WANG ; Yubei HUANG ; Kexin CHEN
Chinese Journal of Preventive Medicine 2021;55(10):1203-1208
Objective:To investigate the potential pleiotropism of cancer-related single nucleotide polymorphisms (SNPs) among Chinese population.Methods:Based on the catalogue of GWAS jointly constructed by the National Human Genome Research Institute and the European Institute of Bioinformatics, according to population origin (Chinese population and non-Chinese population) and disease traits (cancer and non-cancer traits). All SNPs found by GWAS before August 2020 were divided into four categories: cancer in Chinese population, non-cancer in Chinese population, cancer in non-Chinese population and non-cancer in non-Chinese population. The number, correlation and linkage of the four categories of SNPs were described.Results:By August 2020, a total of 196 813 SNPs from 4 096 GWAS were included in the GWAS directory. The information that SNPs refer to unknown or were not related to the disease was excluded, and 117 441 independent SNPs were finally included. There were 619 SNPs related to cancer and 9 569 SNPs related to non-cancer disease in Chinese population, respectively. There were 4 624 SNPs related to cancer and 106 448 SNPs related to non-cancer disease (trait) in non-Chinese population, respectively. Three SNPs, rs2736100, rs6983267 and rs401681, were associated with two or more types of cancer in both Chinese and non-Chinese populations. Seven SNPs, rs7705526, rs2736100, rs10993994, rs2735839, rs4430796, rs174537 and rs9271588, were associated with cancer and non-cancer diseases in both Chinese and non-Chinese populations, respectively.Conclusion:There is a potential pleiotropism of cancer-related SNPs in Chinese population.
6.Biological pacemaker: from biological experiments to computational simulation.
Yacong LI ; Kuanquan WANG ; Qince LI ; Henggui ZHANG
Journal of Zhejiang University. Science. B 2020;21(7):524-536
Pacemaking dysfunction has become a significant disease that may contribute to heart rhythm disorders, syncope, and even death. Up to now, the best way to treat it is to implant electronic pacemakers. However, these have many disadvantages such as limited battery life, infection, and fixed pacing rate. There is an urgent need for a biological pacemaker (bio-pacemaker). This is expected to replace electronic devices because of its low risk of complications and the ability to respond to emotion. Here we survey the contemporary development of the bio-pacemaker by both experimental and computational approaches. The former mainly includes gene therapy and cell therapy, whilst the latter involves the use of multi-scale computer models of the heart, ranging from the single cell to the tissue slice. Up to now, a bio-pacemaker has been successfully applied in big mammals, but it still has a long way from clinical uses for the treatment of human heart diseases. It is hoped that the use of the computational model of a bio-pacemaker may accelerate this process. Finally, we propose potential research directions for generating a bio-pacemaker based on cardiac computational modeling.
7.Performance evaluation of automated magnetic beads extraction method for the measurement of catecholamine metabolites analyzed by liquid chromatography tandem mass spectrometry
Songlin YU ; Xiaoli MA ; Jialei YU ; Ming LI ; Yacong GUO ; Zhendong LIU ; Yutong ZOU ; Danchen WANG ; Wei LUO ; Ling QIU
Chinese Journal of Laboratory Medicine 2022;45(3):268-274
Objective:To evaluate the performance of magnetic beads extraction method (MGE) for the measurement of catecholamine metabolites by liquid chromatography tandem mass spectrometry.Methods:This is a methodological evaluation study. The linearity, limit of quantitation, recovery, precision, and matrix effect of catecholamine metabolites 3-methoxyepinephrine (MN), 3-methoxynorepinephrine (NMN) and 3-methoxytyramine (3-MT) extracted by MGE method were evaluated according to CLSI C62-A. Consensus of method development and validation of liquid chromatography-tandem mass spectrometry in clinical laboratories and other guidelines, 132 clinical residual plasma samples were collected and extracted by automated MGE and traditional solid phase extraction (SPE) method to compare the harmonization of the two extraction methods.Results:The linearity of MN, NMN and 3-MT extracted by automated MGE was>0.99, and the LOQ for MN, NMN and 3-MT were 0.033 5 nmol/L, 0.054 7 nmol/L and 0.011 0 nmol/L, respectively. The repeatability of MN, NMN and 3-MT were 1.3%-5.1%, 2.2%-5.6% and 1.7%-7.1%, respectively. The total imprecision in the laboratory were 1.5%-8.2%, 2.2%-7.7%, 2.1%-11.2%. Although the absolute recovery is low, the average relative recoveries of MN, NMN and 3-MT were 91.5%-108.5%, 92.0%-108.6%, and 89.3%-104.1%, respectively, and the percentage deviation from the expected concentration was within 15%. After isotope internal standard correction, the relative matrix effect is close to 100%, which can compensate for the potential matrix effect. The results of MGE and SPE of MN, NMN and 3-MT showeda good correlation (correlation coefficient r>0.99). The average relative deviations of MN, NMN and 3-MT were 0.2%, -1.4% and 1.0%, respectively. Conclusion:The automatic MGE method hasa good performance in extracting catecholamine metabolites, and is expected to be used in high-throughput analysis of samples in clinical in the future.